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Abstract. Background and aim: One source of error with near-infrared spectroscopy (NIRS) is the assumption
that the measured tissue is optically homogeneous. This is not always the case. Our aim is to assess the impact
of tissue homogeneity (TH) on the precision of NIRS measurements in neonates. Methods: On 36 term and 27
preterm neonates at least five 1-min measurements are performed on each subject using the OxiplexTS. The
sensor position is slightly changed before each measurement while assessing TH. The precision for cerebral tissue
oxygenation saturation (StO2) and total hemoglobin concentration (tHb) are calculated by repeated measures
analysis of variance. Results: The mean StO2 is not significantly different between term and preterm infants. The
mean tHb is significantly lower in preterm infants (p < 0.01). With increasing TH, the precision of StO2 increase
from 5.6 to 4.6% for preterm and from 11.0 to 2.0% for term infants; the precision of tHb increases from 10.1
to 7.5μM for preterm and from 16.4 to 3.5μM for term infants. The precision for StO2 is higher in term than in
preterm infants. The precision for tHb shows no significant difference between the two groups. Conclusions: The
precision of NIRS measurements correlates with tissue homogeneity. C©2011 Society of Photo-Optical Instrumentation Engineers
(SPIE). [DOI: 10.1117/1.3570303]
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1 Background
Neonatal brain injury as a result of perinatal hypoxia-ischemia
remains a common cause of morbidity and mortality in
infants.1, 2 To allow prevention or early intervention, continuous
cerebral monitoring is important to detect cerebral aberrations
in term and preterm neonates undergoing intensive care.3–5
Near-infrared spectroscopy (NIRS) is a continuous and also
noninvasive method to measure regional changes in cerebral tis-
sue oxygenation and perfusion at the bedside.6, 7 Thus, NIRS
is suitable for cerebral monitoring. But until now it has rarely
been used in clinical settings. This could be due to the par-
tially challenging application and to the lack of sufficient
precision necessary to distinguish normal from pathological
conditions.8, 9
In a previous study performed by Soerensen and Greisen,10
the within-infant precision of tissue oxygenation saturation
(StO2) for single measurements was judged to be insuffi-
cient. Using the NIRO 300 (Hamamatsu Photonics, Hamamatsu,
Japan) on 37 preterm infants (mean gestational age 28 weeks),
they performed between three and eight measurements on each
infant. The sensor was replaced before each measurement, pre-
suming that there are no regional differences in cerebral oxy-
genation. The precision of the measurements, defined as the
square root of the within-subject variation, was found to be 5.2%.
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Because of this high value Soerensen and Greisen10 concluded
that it is unfeasible to perform StO2 measurements clinically.
One cause for the dissatisfying precision could have been the
NIRS device used for this study. The NIRO 300 is a continuous-
wave spectroscopy device. To obtain absolute StO2 and total
hemoglobin concentration (tHb) values, a multidistance model
with three detectors and one light source is applied. The tissue
below the sensor is assumed to be flat, semi-infinite, and homo-
geneous, and the light scattering to be at least ten times larger
than absorption. The first two assumptions can be fulfilled by
carefully choosing the measurement area. However, inhomo-
geneity may occur originating from superficial factors, such as
hair, moles, blood vessels and dirt, or from deeper structures
(e.g., larger blood vessels and gyri). These latter can be impos-
sible to see by eye. The assumption that scattering is much higher
than absorption is fulfilled for most tissues in the near-infrared
range. In the case that the tissue underneath the sensor is inho-
mogeneous, the measurement may be inaccurate.11 Therefore,
tissue homogeneity needs to be checked for each measurement.
There is no feature provided for that by the NIRO 300.
In an effort to fulfill this assumption, a different NIRS device,
the OxiplexTS (ISS Inc., Champaign, Illinois) has been used in
our study. It displays slope graphs (Fig. 1) showing the measures
mean intensity (DC), modulation amplitude (AC) and phase shift
(PH) at four distances. If the measured DC, AC, and PH at the
four distances are all precisely on one line, that means that the
tissue is very likely to be homogeneous. In addition, this setup
1083-3668/2011/16(4)/047005/6/$25.00 C© 2011 SPIE
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Fig. 1 Slope graph for homogeneous tissue: The mean intensity
ln[d2*DC(d)], the modulation amplitude ln[d2*AC(d)], and the PH are
linear with respect to the source-detector separation distance d.
has the advantage that it theoretically enables one to identify an
outlier (as long as there is only one), remove it, and obtain correct
data. Please note that in this study we did not take advantage
of this procedure. This does not work for three distances and
is not provided by the NIRO 300, where slope graphs are not
displayed. In addition the OxiplexTS measures the scattering
coefficient directly.
The aim of our study was to first, to determine the precision of
the NIRS measurements in term and preterm infants and second,
to assess the impact of tissue homogeneity on the precision of
NIRS measurements.
2 Patients and Methods
Thirty-six term and twenty-seven preterm infants admitted to
the maternity wards of the Department of Obstetrics and Gy-
necology and to the Division of Neonatology at the University
Hospital Zurich were enrolled in our study. The demographic
data of the neonates are shown in Tables 1 and 2. Infants with
severe birth asphyxia, neurological abnormalities, or severe mal-
formations were excluded. Parental consent was obtained in all
cases prior to enrollment.
Near-infrared spectroscopy was performed using the com-
mercially available OxiplexTS (ISS Inc., Champaign, Illinois)
was provided at first use. This device is based on reflectance
mode multidistance frequency-domain spectroscopy (fd-NIRS)
and features two photomultiplier tubes as detectors and 16
laser diodes as light sources, eight at 692 nm and eight at
834 nm. Multidistance fd-NIRS was introduced by Fantini
et al. and is based on the diffusion approximation to the radiative
transport equation,12 which is solved for photons travelling in
Table 1 Demographic data of term infants.
N = 36 Median Range
Birth weight (g) 3340 2130–4070
Actual weight (g) 3160 2280–3960
Gestational age (weeks) 38.7 37.1–41.3
Postnatal age (days) 4 2–18
Table 2 Demographic data of preterm infants.
N = 27 Median Range
Birth weight (g) 1680 690–2540
Actual weight (g) 1790 730–2700
Gestational age (weeks) 30.9 25.6–35.7
Postnatal age (days) 15 4–60
semi-infinite, homogenously turbid media.13 The emitted light
intensity is sinusoidally modulated at 110 MHz, the time resolu-
tion is 50 Hz. The light is coupled to fibers (400 μm diam) that
guide the light to the tissue. After penetrating the tissue, the light
is received and guided back to the instrument by another fiber
(3 mm diam), where it is detected by a photomultiplier tube.
There are four source-detector distances (d) of 2, 2.5, 3, and
3.5 cm that implement multidistance geometry. The light sources
are turned on one at a time in sequence. At the photomultiplier,
the light that has passed through the tissue is detected and de-
modulated (i.e., DC, AC and PH), with reference to the incident
sinusoidally modulated light, is determined. The main optical
properties of the tissue in the near-infrared range are a high scat-
tering and a much lower absorption coefficient. Because of the
scattering, the path of the light is deflected and totally disordered
after 1 cm of tissue (diffusion process). The scattering and ab-
sorption lead to a decrease in DC and AC with increased source
detector distance. The PH, which corresponds to the photons’
mean time-of-flight increases with the distance traveled and,
hence, the source-detector distance. The decrease in DC or AC is
linear when DC or AC are multiplied with d2 and logarithmized
{i.e., ln[d2*DC(d)], ln[d2*AC(d)]}. The increase in PH(d) is lin-
ear as well. Therefore, a line as a function of d is fitted into the
measured parameters and the resulting slope is used to calculate
the scattering and absorption coefficient of the tissue. From the
absorption coefficient at the two mentioned wavelength oxy-
hemoglobin concentration (O2Hb), deoxy-hemoglobin concen-
tration (HHb), tHb, and StO2, are calculated. These calculations
are correct, provided that the medium is homogeneous. In this
case, the functions ln[d2*DC(d)], ln[d2*AC(d)], and PH(d) are
linear with respect to d. In order to check for tissue homogene-
ity, the instrument displays this linear fitting as slope graphs.
Figure 1 demonstrates the case of a homogeneous medium where
the measured points at the four distances are all on the regres-
sion line. An inhomogeneity is displayed in Fig. 2. At all four
distances, the parameters are not well predicted by the best-
fitted line. This leads to a larger error in the calculated slope and
thus may lead to erroneous values. When an inhomogeneity is
detected, the sensor can be repositioned to find a homogeneous
location and thus perform accurate measurements.
The calibration procedure was carried out as described in the
manual.14 Before each measurement the sensor was placed on
a calibration phantom, which was supplied by ISS Inc. The aim
is to calibrate for instrumental factors (e.g., the difference in
brightness between light sources). These phantoms have known
and highly homogeneous optical properties. They are made of
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Fig. 2 Slope graph for non-homogeneous tissue: Outliers from a lin-
ear function of d in the mean intensity ln[d2*DC(d)], the modulation
amplitude ln[d2*AC(d)], and the PH can be observed. The lines do not
represent the points sufficiently.
solid silicone rubber containing titanium oxide (TiO2) parti-
cles causing scattering and carbon powder causing absorption.
In advance, light sources and detectors warmed up for at least
10 min. Afterward, the sensor was pressed firmly and evenly on
the surface of the calibration block by hand. For correct calibra-
tion, it was essential to assure direct contact for all eight emitters
and the detector bundle with the block surface. A calibration
measurement was started, and the software of the instrument
was calibrated for the instrumental factors.
In a pilot study on a solid calibration phantom, the standard
deviation of StO2 during 20 min (i.e., the time a measurement on
an infant would maximally take) was 0.13%. This corresponds
to the component of instrumental noise.
The sensor was embedded into a soft, medical-grade sili-
cone casing. In order to fulfill the assumptions of semi-infinite
boundary condition and to minimize the amount of variation
in signal due to placement, the sensor was positioned over the
flattest area of the tempoparietal head. Afterward, the sensor
was fixed with an elastic bandage and positioning and pressure
were controlled visually and by palpating. If the sensor was not
placed accurately, then it was repositioned and newly controlled.
In some cases, if the bandage could not be placed adequately,
then the sensor was held in position by hand. Between each
measurement, the sensor was repositioned and the slope graphs
were inspected in order to assess the tissue homogeneity below
the sensor. For each neonate, between 5 and 15 1-min measure-
ments were performed. All measurements were performed by a
single examiner.
Vital parameters, such as heart rate and blood pressure, were
not monitored during the measurements. All term infants were
placed in the maternity ward and were therefore without any
monitoring. The included preterm infants were circulatory and
respiratory stable. Measurements were only performed on silent
and content or sleeping infants; additionally, the total measure-
ment period was <20 min. We therefore assume that vital pa-
rameters were stable and it was the same for all measurements.
Potential fluctuations would lead to a falsely lower precision
(i.e., our precision values are conservative).
As a measure for tissue homogeneity, a self-designed Mat-
lab script calculated the square of the Pearson product-moment
correlation coefficient r2 of the slope graphs. The correlation
coefficient (r2 ranging from 0 to 1) is a widely applied statistical
measure, indicating how well two variables correlate. Specif-
ically, it correlates the source-detector distance d to the mean
of the measured values (AD, DC, PH): r2 = 1, indicating an
entirely linear dependence (i.e., a high tissue homogeneity); r2
= 0 indicates that there is no linear dependence (i.e., a low tissue
homogeneity).
In order to investigate how the inhomogeneity of the tis-
sue affects the precision of the measurements, the results were
grouped by r2 values, calculated for each measurement. Four
categories were defined: r2 ≤ 0.925, 0.925 < r2 < 0.95, 0.95
≤ r2 < 0.975, and r2 ≥ 0.975. If one infant had only one mea-
surement within a certain r2 group, then this single measurement
did not contribute to the within variance of this group. However,
there were enough infants with several measurements per r2
group. Measurements with negative StO2 or negative tHb, and
tHb > 500 μmol/l were excluded.
The precision of StO2 measurement was defined as the
within-infant standard deviation as estimated by the repeated
measures analysis of variance (ANOVA), which considered the
individual subject as a random effect.15 The same algorithm also
yielded the standard deviation of the between-subject variability.
The measurement precision was calculated for every r2 group
by repeated measures ANOVA (IBM SPSS Statistics-Software
Advanced-Models 12.0 and 15.0). Furthermore, a repeated mea-
sures ANOVA was applied to check for statistically significant
differences in the mean StO2 and tHb values between term and
preterm infants.
3 Results
There was no significant difference in the mean StO2 between
term and preterm infants (p = 0.12). However, we found a
significant lower mean tHb in preterm than in term infants
(p < 0.01) (Tables 3 and 4).
Table 3 Results for four categories of tissue homogeneity expressed as r2 in term infants.
r2 N 214 Mean StO2 (%) Precision StO2 (%) Between StO2 (%) Mean tHb (μM) Precision tHb (μM) Between tHb (μM)
<0.925 52/53 74.4 11.0 4.2 60.7 16.4 31.2
0.925 to 0.95 32 72.8 3.1 4.4 57.1 4.0 20.6
0.95 to 0.975 73 75.3 3.1 5.6 57.9 8.2 17.9
>0.975 48 73.1 2.0 6.9 50.0 3.5 16.6
N = total number of measurements, StO2 = tissue oxygenation saturation, Between StO2 = variation between infants, tHb = total hemoglobin
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Table 4 Results for four categories of tissue homogeneity expressed as r2 in preterm infants.
r2 N 161 Mean StO2 (%) Precision StO2 (%) Between StO2 (%) Mean tHb (μM) Precision tHb (μM) Between tHb (μM)
<0.925 31 70.5 5.6 10.1 41.1 4.6 15.2
0.925 to 0.95 24 67.3 5.7 13.4 38.1 4.1 11.3
0.95 to 0.975 42 73.5 4.2 7.6 37.9 6.9 12.0
>0.975 54 72.4 4.6 7.5 34.2 3.1 9.2
N = total number of measurements, StO2 = tissue oxygenation saturation, Between StO2 = variation between infants, tHb = total haemoglobin
Tissue homogeneity, quantified by r2, was assessed to in-
vestigate the effect on the precision of NIRS measurements. As
expected, categories with a higher r2 had lower within-infant and
between-infant variability for StO2 and tHb. Only the between-
infant variability for StO2 in term neonates increased with rising
r2. A higher tissue homogeneity improved the precision for StO2
and tHb significantly in term infants (p = 0.001, respectively,
p = 0.001). No significant difference was demonstrated in
preterm infants (Tables 3 and 4). The absorption and scattering
coefficients of the infants’ head for different gestational ages are
given in Table 5.
4 Discussion
In modern neonatology, a noninvasive method for continuous
cerebral monitoring in term and preterm neonates undergoing
intensive care is a tremendous demand. Currently, there exists
no established method to provide quantitative and qualitative
information on cerebral parameters in a clinical routine and
hence enable us to detect cerebral pathologies more easily and
sooner.
NIRS is a noninvasive method to measure continuously re-
gional changes in cerebral tissue oxygenation and perfusion.6, 7
There is even the possibility to perform functional brain activity
measurements.16 In a clinical setting, for NIRS devices it is im-
portant to feature a sufficient precision allowing distinguishing
normal from pathological conditions. There are several NIRS
devices commercially available based on different technologies,
with individual strengths and limitations.
Menke et al. were the first to provide data on the precision17
of NIRS measurements. Using the Critikon 2020 (Johnson and
Johnson Medical, Newport, United Kingdom) for StO2, they
maintained a very low within-infant and between-infant varia-
tion (1.7%, respectively, 4.1%) in neonates. However, this de-
vice has been shown to underestimate true variability of StO2
measurements,18, 19 which probably explains the low values.
The mentioned study performed by Soerensen and Greisen,10
using the NIRO 300 (Hamamatsu), revealed for StO2 a within-
infant precision of 5.2% for single measurements. By averaging
multiple measurements, the error improved by 2.3%. However,
averaging is not very practical in a clinical setting. The need
of multiple measurements prolongs the intervention time and
therefore, increases the stress on the fragile and maybe instable
infants undergoing intensive care.
Our results showed no significant difference between the
74.5% mean StO2 in term infants and the 71.8% in preterm
infants (p = 0.12). Van Bel et al.20 summarized nicely normal
values of StO2 in adults, term and preterm infants ranging from
58 to 75%, respectively, 49 to 75% and 54 to 85%. In accordance
with our results, they reported no significant difference between
the different groups.
In contrary, the mean tHb differs with high significance
between term (55.1 μmol/l) and preterm (39.6 μmol/l) in-
fants (p < 0.01). These results are clearly lower than the
98.8 μmol/l mean tHb obtained in 20 term infants by our group
earlier.21 This is probably due to the quite different algorithms.
Whereas the 66% mean StO2 differs only little from our current
results.
Table 5 Mean ± standard deviation absorption and scattering coefficients and respective differential pathlength factors (DPF) of the infant’s head
for different gestational ages.
GA N μa 692 nm μ′s 692 nm DPF 692 nm μa 834 nm μ′s 834 nm DPF 834 nm
30–31 2 0.064 ± 0.008 5.0 ± 0.9 5.6 ± 0.9 0.079 ± 0.002 4.0 ± 0.9 4.5 ± 0.7
32–33 7 0.080 ± 0.020 4.1 ± 1.8 4.4 ± 1.2 0.104 ± 0.021 3.3 ± 1.5 3.5 ± 1.0
34–35 13 0.088 ± 0.027 4.3 ± 1.3 4.5 ± 0.8 0.106 ± 0.027 3.3 ± 1.0 3.5 ± 0.7
36–37 3 0.094 ± 0.028 5.9 ± 2.7 5.2 ± 1.3 0.102 ± 0.025 4.6 ± 2.1 4.3 ± 1.0
38–39 16 0.118 ± 0.036 5.3 ± 2.3 4.4 ± 1.3 0.148 ± 0.042 4.0 ± 1.7 3.4 ± 1.1
40–41 12 0.131 ± 0.027 5.7 ± 1.7 4.5 ± 0.6 0.161 ± 0.030 4.1 ± 0.9 3.5 ± 0.4
GA = gestational age (weeks), N = total number of infants, μa = absorption coefficient (1/cm), μ′s = scattering coefficient (1/cm)
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Likewise Raj et al. showed that healthy children had a similar
mean StO2 (72%), whereas children with sickle cell disease and
mild symptoms had a low mean StO2 (62%) and even lower
value (48%) with severe symptoms.22 This could be expected,
given that a low tHb increases oxygen extraction and thus leads
to a lower StO2. The lower mean tHb in preterm compared to
term infants is in accordance with the well-known anemia of
prematurity caused by physiologically and in a clinical setting
iatrogenically reduced red blood cell mass and iron stores.23–25
Interestingly, Naulaers et al. revealed, depending on the post-
natal age of the preterm infant, a significant rise in mean StO2
from 57 to 66% (p = 0.05) between days 1 and 2 and from 66
to 76% (p = 0.001) between days 2 and 3.26 The increase in
StO2, depending on the postnatal age, could be connected with
the continuing increase in blood volume correlated to myelina-
tion changes during the postnatal cerebral development. This
could be due to higher energy consumption during myelination
or increased cerebral activity.
Franceschini et al., however, demonstrated that StO2 stayed
constant in 47 term and preterm infants [range 27.0–41.5 weeks
gestational age (GA)] within the first year of life. The average
StO2 was 64%. Their stable values for StO2 might be due to
a close interaction between oxygen delivery and oxygen con-
sumption, shown by a significant increase of 84%, respectively,
50% in cerebral blood flow and tHb.27
In our study, the range for the postnatal age was wide with
2–18 days in term and especially with 4–60 days in preterm
infants. The data showed no relation to gestational age or post-
natal age. This could be due to lack of repeated measurements
in the same infants; additionally, our protocol was not designed
to detect such changes.
The precision of StO2 measurement was defined as the
within-infant variation. Depending on the correlation coeffi-
cient category, representing tissue homogeneity, the within-
infant variation for StO2 and tHb varied significantly in term
infants (p = 0.001 for both). Indeed, a higher homogeneity
leads to a significantly higher precision (i.e., lower within-infant
variation). For preterm infants, although the values showed the
same tendency, the difference in precision in relation to the tis-
sue homogeneity was smaller and not significant. This probably
is one of the particularities of our data set, and we do not have
a reasonable explanation for this effect. Thus, a higher tissue
homogeneity and optimization of the measurement condition
leads to improved within-infant variation in term, but less so or
not in preterm infants.
In parallel, the between-infant variation for StO2 in preterm
and the between-infant variation for tHb in term and preterm
neonates decrease significantly (p = 0.001 for all three), de-
pending on the correlation coefficient category. By comparison,
Soerenson and Greisen10 obtained a between-infant StO2 vari-
ation of 6.9%. The within-infant StO2 variation of 5.2% was
almost as high, which makes it difficult to observe differences
of measurements between different infants.6
To apply NIRS clinically [i.e., to distinguish subjects in a
critical ill situation (e.g. hypoxia) from healthy subjects], two
prerequisites must be fulfilled. First, measurements must be suf-
ficiently precise, or the more precise measurements are, the bet-
ter. Second, the values of subjects in a critically ill situation
must be sufficiently different from the range of values in healthy
infants, as expressed by the between-infant variation. The lat-
ter still must be established in clinical trials. In our data, the
between-infant variation generally decreased with tissue homo-
geneity, probably as a result of the decrease in variability within
infants. This means that higher tissue homogeneity increases the
chances that the method yields clinically relevant results.
In conclusion, NIRS measurements performed in our study
presented a higher precision in term than in preterm infants.
The precision of NIRS measurements can be improved signifi-
cantly in term infants by ascertaining high tissue homogeneity
for each measurement. In preterm infants, the precision of the
measurements was smaller and not significant. Considering that
especially preterm infants often require cerebral monitoring, the
future aim must be the improvement of NIRS devices to ob-
tain higher precision, enabling us to monitor cerebral oxygena-
tion in a routine clinical setting and thereby preventing cerebral
pathology.
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